Skip to main content
SpringerLink
Log in
Book cover

Management of Acute Coronary Syndromes pp 383–405Cite as

Risk Stratification: Exercise Testing, Imaging, and Cardiac Catheterization

  • Chapter

  • 63 Accesses

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

Each year, approximately 1.5 million patients in the United States suffer an acute myocardial infarction (AMI) and 500,000 patients die (1). Reperfusion therapy, increased use of adjunctive medication such as aspirin, β-blockers, angiotensin-converting enzyme (ACE) inhibitors, and hypocholesterolemic treatment coupled with better risk stratification to identify those most likely to benefit from early coronary revascularization has led to significant improved long-term prognosis after myocardial infarction (MI).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Heart Association. 1997 Heart and Stroke Facts. American Heart Association, 1997.

    Google Scholar 

  2. Hillis LD, Forman S, Braunwald E, and the Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-investigators. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1990; 16: 313–315.

    PubMed  CAS  Google Scholar 

  3. Normand ST, Glickman ME, Sharma RG, McNeil BJ. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the C000perative Cardiovascular Project. JAMA 1996; 275: 1822–1828.

    Google Scholar 

  4. Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, et al. Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 1996; 27: 1119–1127.

    PubMed  CAS  Google Scholar 

  5. Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute MI. National Registry of Myocardial Infarction. Ann Intern Med 1996; 124: 283–291.

    PubMed  CAS  Google Scholar 

  6. Aguirre FV, McMahon RP, Mueller H, Kleiman NS, Kern MJ, Desvigne-Nickens P, et al., for the TIMI II investigators. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II study. Circulation 1994; 90: 78–86.

    PubMed  CAS  Google Scholar 

  7. Lee KL, Woodlieg LM, Topol EJ, Weaver D, Bertrin J, Califf RM. Predictors of 30 day mortality in the era of reperfusion for acute myocardial infarction. Results from international trial of 41,021 patients. Circulation 1995; 91: 1659–1663.

    PubMed  CAS  Google Scholar 

  8. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–322.

    Google Scholar 

  9. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 1995; 91: 1861–1871.

    PubMed  CAS  Google Scholar 

  10. Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerd A, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-1 Investigators. JAMA 1996; 275: 777–782.

    PubMed  CAS  Google Scholar 

  11. Kober L, Torp-Pedersen C, Ottesen M, Rasmussen S, Lessing M, Skagen K, and the TRACE study group. Influence of gender on short-and long-term mortality after acute myocardial infarction. Am J Cardiol 1996; 77: 1052–1056.

    Google Scholar 

  12. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol 1989; 14: 49–57.

    PubMed  CAS  Google Scholar 

  13. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 1993; 21: 920–925.

    PubMed  CAS  Google Scholar 

  14. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126: 296–306.

    PubMed  CAS  Google Scholar 

  15. Abbot RD, Donaue R, Kannei WB. The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA 1988; 260: 3456–3460.

    Google Scholar 

  16. Abbud ZA, Shindler DM, Wilson AC, Kostis JB. Effect of diabetes mellitus on short-and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J 1995; 130: 51–58.

    PubMed  CAS  Google Scholar 

  17. Taylor HA, Chaitman BR, Rogers WJ, Kern MJ, Terrin ML, Aguirre FV, et al. TIMI Investigators. Race and prognosis after myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. Circulation 1993; 88: 1484–1494.

    PubMed  CAS  Google Scholar 

  18. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA. Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med 1993; 329: 73–78.

    PubMed  CAS  Google Scholar 

  19. Mueller HS, Cohen LH, Braunwald E, Forman S, Feit F, Ross A. Predictors of early mortality and morbidity after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in TIMI-II trial. Circulation 1992; 85: 1254–1264.

    PubMed  CAS  Google Scholar 

  20. Killiip T 3d, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20: 456–464.

    Google Scholar 

  21. Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 1976; 295: 1356–1362.

    PubMed  CAS  Google Scholar 

  22. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 1994; 330: 1724.

    PubMed  CAS  Google Scholar 

  23. O’Gara PT. Primary pump failure. In: Fuster V, Ross R, Topol E, eds. Atherosclerosis and Coronary Artery Disease. Raven Press, New York, 1995, p. 1051.

    Google Scholar 

  24. Bates ER, Topol EJ. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991; 18: 1077.

    PubMed  CAS  Google Scholar 

  25. Holmes DR, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 trial experience. J Am Coll Cardiol 1995; 26: 668.

    PubMed  Google Scholar 

  26. Birnbaum Y, Herz I, Sclarovsky S, Zlotikamien B, Chetrit A, Olmer L, et al. Prognostic significance of the admission electrocardiogram in acute myocardial infarction. J Am Coll Cardiol 1996; 27: 1128–1132.

    PubMed  CAS  Google Scholar 

  27. Bates ER, Clemmensen PM, Califf RM, Gorman LE, Aronson LG, George BS, et al. Precordial ST segment depression predicts a worse prognosis in inferior infarction despite reperfusion therapy. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 1990; 16: 1538–1544.

    PubMed  CAS  Google Scholar 

  28. Wong CK, Freedman SB, Bautovich G, Bailey BP, Bernstein L, Kelly DT. Mechanisms and significance of precordial ST-segment depression during inferior wall acute myocardial infarction associated with severe narrowing of the dominant right coronary artery. Am J Cardiol 1993; 71: 1025.

    PubMed  CAS  Google Scholar 

  29. Peterson ED, Hathaway WR, Zabel KM, Pieper KS, Granger CB, Wagner GS, et al. Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients. J Am Coll Cardiol 1996; 28: 305–312.

    PubMed  CAS  Google Scholar 

  30. Birnbaum Y, Herz I, Sclaraovsky S, Ziotikamien B, Chetrit A, Barbash G. Prognostic significance of different patterns of precordial ST segment depression in inferior wall acute MI. J Am Coll Cardiol 1995; 343A.

    Google Scholar 

  31. Zehender M, Kasper M, Kauder E, Schorrthaler M, Geibel A, Olschewski M, et al. Right ventricular infaction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993; 218: 981–988.

    Google Scholar 

  32. Newby KH, Natale A, Krucoff MW, Morris KG, Trollinger K, Shah A, et al. The incidence and clinical relevance of bundle branch block in patients with acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol 1995; 343A.

    Google Scholar 

  33. Shecter M, Rabinowitz B, Beker B, Motro M, Barbash G, Kaplinski E. Additional ST segment elevation during the first hour of thrombolytic therapy, an electrocardiographic sign predicting a favorable clinical outcome. J Am Coll Cardiol 1992; 20: 1460–1464.

    Google Scholar 

  34. Mauri F, Maggioni AP, Franzosi MG, DeVita C, Santoro E, Santoro L, et al., for the GISSI-2 investigators. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per to Studio della Sopravvienza nell’Infarto Miocardico (GISSI-2)-Derived Analysis. J Am Coll Cardiol 1994; 24: 600–607.

    PubMed  CAS  Google Scholar 

  35. Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer-Sabellek W, for the INJECT Trial Group. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) Trial. J Am Coll Cardiol 1995; 26: 1657–1664.

    PubMed  Google Scholar 

  36. Silver MT, Rose GA, Paul SD, O’Donnell CJ, O’Gara PT, Eagle KA. A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarction. Ann Intern Med 1994; 121: 750–756.

    PubMed  CAS  Google Scholar 

  37. Shaw LJ, Peiper K, Peterson ED, Eagle KA, Wagner GS, Califf RM. Optimization of resources by efficient use of readily available simple clinical measures in a high-risk post-myocardial infarction population. Presented at the 13th Annual Meeting of the Association for Health Service Research, Atlanta, GA, June 9–11, 1996.

    Google Scholar 

  38. Brodie BR, Weintraub RA, Stuckey TD, LeBauer EJ, Katz JD, Kelly TA, et al. Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. Am J Cardiol 1991; 67: 7–12.

    PubMed  CAS  Google Scholar 

  39. Himbert D, Juliard JM, Steg PG, Badaoui G, Baleynaud S, Le Guludec D, et al. Primary coronary angioplasty for acute myocardial infarction with contraindication to thrombolysis. Am J Cardiol 1993; 71: 377–381.

    PubMed  CAS  Google Scholar 

  40. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995; 91: 476–485.

    PubMed  CAS  Google Scholar 

  41. Ellis SG, Ribeiro da Silva E, Heyndrickx GR, Talley JD, Cernigliaro C, Steg G, et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1996; 90: 2280–2284.

    Google Scholar 

  42. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 1996; 28: 1328–1428.

    PubMed  CAS  Google Scholar 

  43. Reeder GS. Identification and management of the low-risk patient after myocardial infarction. ACC Curr J Rev 1997;May/June:27–31.

    Google Scholar 

  44. Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med 1997; 126: 561–582.

    PubMed  CAS  Google Scholar 

  45. Mark DB, Sigmon K, Topol EJ, Kereiakes DJ, Pryor DB, Candela RJ, et al. Identification of acute myocardial infarction patients suitable for early hospital discharge after aggressive intervention therapy: results from the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry. Circulation 1991; 83: 1186–1193.

    PubMed  CAS  Google Scholar 

  46. Villela A, Maggioni AP, Villela M, Girodano A, Turazza FM, Santoro E, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 database. Lancet 1995; 346: 523–529.

    Google Scholar 

  47. Newby KL, Califf RM, Guerci A, Weaver WD, Col J, Horgan JM, et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the GUSTO trial. J Am Coll Cardiol 1996; 27: 625–632.

    PubMed  CAS  Google Scholar 

  48. Mueller HS, Forman SA, Mengens MA, Cohen LS, Knatterud GL, Braunwald E. Prognostic significance of nonfatal reinfarction during 3 year follow-up: results of the TIMI phase II trial. J Am Coll Cardiol 1995; 26: 900–907.

    PubMed  CAS  Google Scholar 

  49. Barbagelata A, Granger CB, Topol EJ, Worley SJ, Kreikas DJ, George BS, et al. Frequency, significance and cost of recurrent ischemia after thrombolytic therapy for myocardial infarction. Am J Cardiol 1995; 76: 1007–1013.

    PubMed  CAS  Google Scholar 

  50. Figuerdo V, Cheitlin MD. Risk stratification. In: Julain DG, Braunwald E, eds. Management of Acute Myocardial Infarction. WB Saunders, London, 1994, pp. 361–391.

    Google Scholar 

  51. Theroux P, Juneau M. Exercise and pharmacologic testing after acute myocardial infarction In: Francis GS, Albert JS, eds. Coronary Care. Little, Brown, Boston 1993, pp. 615–628.

    Google Scholar 

  52. DeBuskRF. Specialized testing after recent acute myocardial infarction. Ann Intern Med 1989; 110: 470.

    Google Scholar 

  53. Topol EJ, Bates ER, Walton JA Jr, et al. Coronary angiography after thrombolytic therapy for acute myocardial infarction. Ann Intern Med 1991; 114: 877–885.

    PubMed  CAS  Google Scholar 

  54. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. N Engl J Med 1989; 329: 618–627.

    Google Scholar 

  55. Williams DO, Braunwald E, Knatterud G, TIMI Investigators. One-year results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) Phase II Trial. Circulation 1992; 85: 533–542.

    PubMed  CAS  Google Scholar 

  56. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. SWIFT trial of delayed elective intervention versus conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ 1991;302:555–560.

    Google Scholar 

  57. Multicentre Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331–336.

    Google Scholar 

  58. Volpi A, DeVita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, et al., the Ad Hoc Working Group of the Gruppo Italiano per to Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-2 database. Determinants of the 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 database. Circulation 1993; 88: 416–429.

    PubMed  CAS  Google Scholar 

  59. Warnowicz MA, Parker H, Chetlin MD. Prognosis of patients with acute pulmonary edema and normal ejection fraction after acute myocardial infarction. Circulation 1983; 67: 330–334.

    PubMed  CAS  Google Scholar 

  60. Gibson RS, Bishop HL, Stamm RB, Crampton RS, Beller GA, Martin RP. Value of early two-dimensional echocardiography in patients with acute myocardial infarction. Am J Cardiol 1982; 49: 1110–1119.

    PubMed  CAS  Google Scholar 

  61. Horowitz RS, Morganroth J, Parrotto C, Chun CC, Soffer J, Pauletto FJ. Immediate diagnosis of acute myocardial infarction by two-dimensional echocardiography. Circulation 1982; 65: 323–329.

    PubMed  CAS  Google Scholar 

  62. Nishimura RA, Tajek AJ, Shub C, Miller FA, Ilstrip DM, Harrison CE. Role of two-dimensional echocardiography in the prediction of inhospital complications after acute myocardial infarction. J Am Coll Cardiol 1984; 4: 1080–1087.

    PubMed  CAS  Google Scholar 

  63. Jaarsma W, Visser CA, Eemgevan MJ, Verhengt FW, Kupper AJ. Predictive value of two-dimensional echocardiography and hemodynamic measurements on admission with acute myocardial infarction. J Am Soc Echocardiogr 1988; 1: 187–193.

    PubMed  CAS  Google Scholar 

  64. Saabia P, Abbott RD, Afrookteh A, Keller MW, Touchstone DA, Karl S. Importance of two dimensional echocardiographic assessment of left ventricular function in patients presenting to emergency room with cardiac related symptoms. Circulation 1991; 84: 1615–1624.

    Google Scholar 

  65. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44.

    PubMed  CAS  Google Scholar 

  66. Reeder GS, Gibbons RJ. Acute myocardial infarction: risk stratification in the thrombolytic era. Mayo Clin Proc 1995; 70: 87–94.

    PubMed  CAS  Google Scholar 

  67. Pilote L, Silberberg J, Lisbona R, Sniderman A. Prognosis in patients with low left ventricular ejection fraction after myocardial infarction. Circulation 1989; 80: 1636.

    PubMed  CAS  Google Scholar 

  68. Chaitman BR, McMahon RP, Ten-in M, Younis LT, Shaw LJ, Weiner DA, et al. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II trial. Am J Cardiol 1993; 71: 131–138.

    PubMed  CAS  Google Scholar 

  69. Villella A, Maggioni AP, Villella M, Giordano A, Turazza FM, Santoro E, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 database. Lancet 1995; 346: 523–529.

    PubMed  CAS  Google Scholar 

  70. Stevenson R, Umachandran V, Ranjandayalan K, Wilkinson P, Marchant B, Timms AD. Reassessment of treadmill stress testing for risk stratification in patients with acute myocardial infarction treated with thrombolysis. Br Heart J 1993; 70: 415–420.

    PubMed  CAS  Google Scholar 

  71. Arnold AE, Simoons ML, Detry JM, von Essen R, Van de Werf F, Deckers JW, et al. Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography? The European Cooperative Study Group. Eur Heart J 1993; 14: 306–315.

    PubMed  CAS  Google Scholar 

  72. Toft E. Neilson G, Mortenson B, Dalsgaard D, Mansen JB, Rasmussen K. The prognostic value of exercise testing early after myocardial infarction in patients treated with thrombolytics. Eur Heart J 1995; 16: 1177–1180.

    PubMed  CAS  Google Scholar 

  73. Piccalo G, Pirelli S, Massa D, Cipriani M, Sarullo FM, De Vita C. Value of negative predischarge exercise testing in identifying patients at low risk after acute myocardial infarction treated by systemic thrombolysis. Am J Cardiol 1992; 70: 31–33.

    PubMed  CAS  Google Scholar 

  74. Khattar RS, Basu SK, Ranal V, Senior R, Lahiri A. Prognostic value of predischarge exercise testing, ejection fraction and ventricular ectopic activity in acute myocardial infarction treated with streptokinase. Am J Cardiol 1996; 78: 136–114.

    PubMed  CAS  Google Scholar 

  75. Juneau M, Colles P, Theroux P, de Guise P, Pelletier G, Lam J, et al. Symptom-limited versus low level exercise testing before hospital discharge after myocardial infarction. J Am Coll Cardiol 1992; 20: 927–933.

    PubMed  CAS  Google Scholar 

  76. Jain A, Myers GH, Sapin PM, O’Rourke RA. Comparison of symptom-limited and low level exercise tolerance tests early after myocardial infarction. J Am Coll Cardiol 1993; 22: 1816–1820.

    PubMed  CAS  Google Scholar 

  77. Shaw LJ, Peterson ED, Kesler K, Hasselblad V, Califf RM. A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion and ventricular function imaging. Am J Cardiol 1996; 78: 1327–1337.

    PubMed  CAS  Google Scholar 

  78. Ritchie JL, Gibbons RJ, Cheitlin MD, Eagle KA, Gardner Ti, Garson A, et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30: 260–315.

    PubMed  Google Scholar 

  79. Miller TD, Gersh BJ, Christian TF, Bailey KR, Gibbons RJ Limited prognostic value of thallium-201 exercise treadmill testing early after myocardial infarction in patients treated with thrombolysis. Am Heart J 1995; 130: 259–266.

    PubMed  CAS  Google Scholar 

  80. Tilkemeier PL, Guiney TE, LaRaia PJ, Boucher CA. Prognostic value of predischarge low-level exercise thallium testing after thrombolytic treatment of acute myocardial infarction. Am J Cardiol 1990; 66: 1203–1207.

    PubMed  CAS  Google Scholar 

  81. Hendel RC, Gore JM, Alpert JS, Leppo JA. Prognosis following interventional therapy for acute myocardial infarction utility of dipyridamole thallium scintigraphy. Cardiology 1991; 79: 73–80.

    PubMed  CAS  Google Scholar 

  82. Bowling BA, Aljuni SC, Puchrowicz S, Juni JE, Grines CE. Assessing the utility of exercise nuclear scintigraphy after reperfusion following myocardial infarction. Circulation 1992; 86 (Suppl I): I - 136.

    Google Scholar 

  83. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 1995; 25: 1333–1340.

    PubMed  CAS  Google Scholar 

  84. Basu S, Senior R, Dore C, Lahiri A. Value of thallium 201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients. BMJ 1996; 313: 844–848.

    PubMed  CAS  Google Scholar 

  85. Travin myocardial infarction, Dessouki A, Cameron T, Heller GV. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1985; 75: 665–669.

    Google Scholar 

  86. Dakik MA, Mahmarian JK, Kimball KT, Koutelow MG, Medrano R, Verani MS. Prognostic value of exercise T1–201 tomography in patients treated with thrombolytic therapy during myocardial infarction. Circulation 1996; 94: 2735–2742.

    PubMed  CAS  Google Scholar 

  87. Leppo JA, O’Brien J, Rothendler JA, Getchell JD, Lee VW. Dipyridamole thallium 201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984; 310: 1014–1018.

    PubMed  CAS  Google Scholar 

  88. Brown KA, O’Meara J, Chambers CE, Plante DA. Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict inhospital and late recurrent ischemic events. Am J Cardiol 1990; 65: 160–167.

    PubMed  CAS  Google Scholar 

  89. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995; 92: 334–341.

    PubMed  CAS  Google Scholar 

  90. Ryan T, Armstrong WF, O’Donnell JA, Feigenbaum H. Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 1987; 114: 1305–1316.

    PubMed  CAS  Google Scholar 

  91. Applegate RJ, Dell’ Italia LJ, Crawford MH. Usefulness of two-dimensional echocardiography during low-level exercise testing early after uncomplicated acute myocardial infarction. Am J Cardiol 1987; 60: 10–14.

    PubMed  CAS  Google Scholar 

  92. Quintana M, Lindvall K, Ryden L, Brolund F. Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction. Am J Cardiol 1995; 76: 1115–1121.

    PubMed  CAS  Google Scholar 

  93. Smart SC, Knickelbine T, Stoiber TR, Carlos M, Wynsen JC, Sagar KB. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Circulation 1997; 95: 1394–1401.

    PubMed  CAS  Google Scholar 

  94. Carlos ME, Smart SC, Wynsen JC, Sagar KB. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997; 95: 1402–1410.

    PubMed  CAS  Google Scholar 

  95. Iliceto S, Caiali C, Ricci A. Prediction of cardiac events after uncomplicated myocardial infarction by cross-sectional echocardiography during transesophageal atrial pacing. Int J Cardiol 1990; 28: 95–103.

    PubMed  CAS  Google Scholar 

  96. Bolognese L, Rossi L, Sarasso G, Prando MD, Brongo AS, Dellavesa P, et al. Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. J Am Coll Cardiol 1992; 19: 953–959.

    PubMed  CAS  Google Scholar 

  97. Camerici, Picano E, Landi P. Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. J Am Coll Cardiol 1993; 22: 1809–1815.

    Google Scholar 

  98. Picano E, Pingitore A, Sicari R, Minardi G, Gandolfo N, Seveso G, et al. Stress echocardiographic results predict risk reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. J Am Coll Cardiol 1995; 26: 908.

    PubMed  CAS  Google Scholar 

  99. Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ, et al. Guidelines for clinical use of cardiac radionuclide imaging: report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging) developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 1995; 25: 521–527.

    PubMed  CAS  Google Scholar 

  100. Cheitlin MD, Alpert JS, Armstrong WF, Aurigennna GP, Bierman FZ, Beller GA, et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 1997; 95: 1686–1744.

    CAS  Google Scholar 

  101. Pfeffer MA, Braunwald E, Moye LA, on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669–667.

    PubMed  CAS  Google Scholar 

  102. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, et al., on behalf of GISSI-2 investigators. Prevalence and prognostic significance of ventricular arrhythmia after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993; 87: 312–322.

    PubMed  CAS  Google Scholar 

  103. Moss AJ, Davis HJ, DeCamilla J, Bayer LW. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac deaths after myocardial infarction. Circulation 1979; 60: 998–1003.

    PubMed  CAS  Google Scholar 

  104. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM, and the Multicenter Post-Infarction Research Group. The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 1984; 69: 250–258.

    Google Scholar 

  105. Mukharji J, Rude RE, Poole WK. The myocardial infarctionLlS study group. Risk factors for sudden death after acute myocardial infarction. Two year follow-up. Am J Cardiol 1984; 54: 31–36.

    PubMed  CAS  Google Scholar 

  106. McClements BM, Adgey AAJ. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1993; 21: 1419–1427.

    PubMed  CAS  Google Scholar 

  107. Singh N, Mironov D, Armstrong PW, Ross AM, Langer A, for the GUSTO ECG Substudy Investigators. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. Circulation 1996; 93: 1388–1395.

    PubMed  CAS  Google Scholar 

  108. Farrell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991; 18: 687–697.

    PubMed  CAS  Google Scholar 

  109. Reinhardt L, Makijarvi M, Fetsch T, Schulte G, Sierra G, Martinez-Rubio A, et al. Noninvasive risk modeling after myocardial infarction. Am J Cardiol 1996; 78: 627–632.

    PubMed  CAS  Google Scholar 

  110. Fei L, Copie X, Malik M, Camm AJ. Short-and long-term assessment of heart rate variability for risk stratification after acute myocardial infarction. Am J Cardiol 1996; 77: 681–684.

    PubMed  CAS  Google Scholar 

  111. Denes P, el-Sherif N, Katz R, Capone R, Carlson M, Mitchell LB, et al. Prognostic significance of signal-averaged electrocardiogram after thrombolytic therapy and/or angioplasty during acute myocardial infarction (CAST substudy). Cardiac Arrhythmia Suppression Trial (CAST) SAECG Substudy Investigators. Am J Cardiol 1994; 74: 216–220.

    PubMed  CAS  Google Scholar 

  112. Richards DA, Blyth K, Ross DL, Uther JB. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation 1991; 83: 756–763.

    PubMed  CAS  Google Scholar 

  113. Zoni-Berisso M, Molini D, Mela GS, Vecchio C. Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction. Am J Cardiol 1996; 77: 673–680.

    PubMed  CAS  Google Scholar 

  114. Pedretti R, Etro MD, Laporta A, Braga SS, Caru B. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 1993; 71: 1131–1141.

    PubMed  CAS  Google Scholar 

  115. Moss AJ, Hall J, Cannom DS, Dauberg JP, Higgins SL, Klein H, et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933–1940.

    PubMed  CAS  Google Scholar 

  116. Ellis SG, Mooney MR, George GS, da Silva EE, Talley JD, Flanagan WH, et al., for the Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Circulation 1992; 86: 1400–1406.

    PubMed  CAS  Google Scholar 

  117. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994; 331: 1130–1135.

    PubMed  CAS  Google Scholar 

  118. Rouleau JL, Moye LA, Pfeffer MA, Arnold JM, for the SAVE investigators. A comparison of management patterns after acute myocardial infarction in Canada and United States-the SAVE investigators. N Engl J Med 1993; 328: 779–784.

    PubMed  CAS  Google Scholar 

  119. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Rubenson RM, Weaner WD, for Participants of National Registry of Myocardial Infarction. Treatment of myocardial infarction in the United States (1990–1993). Observations from National Registry of Myocardial Infarction. Circulation 1994; 90: 2103–2114.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Sanjeev Puri MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernard R. Chaitman MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Christopher P. Cannon MD

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Puri, S., Chaitman, B.R. (1999). Risk Stratification: Exercise Testing, Imaging, and Cardiac Catheterization. In: Cannon, C.P. (eds) Management of Acute Coronary Syndromes. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-731-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-731-4_15

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5706-4

  • Online ISBN: 978-1-59259-731-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation